For the year ending 2025-12-31, XTNT made $133,927K in revenue. $4,973K in net income. Net profit margin of 3.71%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 133,927 | 115,765 | ||
| Cost of sales | 49,654 | 49,051 | ||
| Gross profit | 84,273 | 68,216 | ||
| General and administrative | 29,375 | 28,691 | ||
| Sales and marketing | 45,512 | 49,214 | ||
| Research and development | 2,102 | 2,385 | ||
| Total operating expenses | 76,989 | 80,290 | ||
| Income (loss) from operations | 7,284 | -12,074 | ||
| Interest expense | 3,671 | 4,160 | ||
| Interest income | 94 | - | ||
| Unrealized foreign currency translation (loss) gain | -60 | 5 | ||
| Gain on divestiture | 3,281 | - | ||
| Other income (expense) | 73 | -33 | ||
| Total other (expense) income | -283 | -4,188 | ||
| Net income (loss) from operations before provision for income taxes | 7,001 | -16,262 | ||
| Provision for income taxes current and deferred | 2,028 | 187 | ||
| Net income (loss) | 4,973 | -16,449 | ||
| Basic EPS | 0.04 | -0.12 | ||
| Diluted EPS | 0.03 | -0.12 | ||
| Basic Average Shares | 139,531,791 | 133,665,075 | ||
| Diluted Average Shares | 150,042,556 | 133,665,075 | ||
Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. (XTNT)